KalVista Pharmaceuticals (KALV) Long-Term Debt Repayments (2018 - 2020)
KalVista Pharmaceuticals' Long-Term Debt Repayments history spans 3 years, with the latest figure at $1000.0 for Q2 2020.
- On a quarterly basis, Long-Term Debt Repayments fell 98.15% to $1000.0 in Q2 2020 year-over-year; TTM through Apr 2020 was $54000.0, a 74.16% decrease, with the full-year FY2020 number at $54000.0, down 74.16% from a year prior.
- Long-Term Debt Repayments hit $1000.0 in Q2 2020 for KalVista Pharmaceuticals, up from -$1000.0 in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for KALV hit a ceiling of $54000.0 in Q2 2019 and a floor of -$1000.0 in Q1 2020.
- Historically, Long-Term Debt Repayments has averaged $40555.6 across 3 years, with a median of $52000.0 in 2018.
- Biggest five-year swings in Long-Term Debt Repayments: rose 8.0% in 2019 and later tumbled 101.96% in 2020.
- Tracing KALV's Long-Term Debt Repayments over 3 years: stood at $52000.0 in 2018, then grew by 3.85% to $54000.0 in 2019, then crashed by 98.15% to $1000.0 in 2020.
- Business Quant data shows Long-Term Debt Repayments for KALV at $1000.0 in Q2 2020, -$1000.0 in Q1 2020, and $54000.0 in Q3 2019.